These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 10618802)
21. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292 [TBL] [Abstract][Full Text] [Related]
22. CARRISMA: a new tool to improve risk stratification and guidance of patients in cardiovascular risk management in primary prevention. Gohlke H; Winter M; Karoff M; Held K Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):141-8. PubMed ID: 17301640 [TBL] [Abstract][Full Text] [Related]
23. Evidence-based guidelines, time-based health outcomes, and the Matthew effect. Essink-Bot ML; Kruijshaar ME; Barendregt JJ; Bonneux LG Eur J Public Health; 2007 Jun; 17(3):314-7. PubMed ID: 17060334 [TBL] [Abstract][Full Text] [Related]
24. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan. Morimoto T; Fukui T; Lee TH; Matsui K Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702 [TBL] [Abstract][Full Text] [Related]
25. Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology. Graham IM; Stewart M; Hertog MG; Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):839-45. PubMed ID: 17001227 [TBL] [Abstract][Full Text] [Related]
26. GPs' views of absolute cardiovascular risk and its role in primary prevention. Torley D; Zwar N; Comino EJ; Harris M Aust Fam Physician; 2005 Jun; 34(6):503-4, 507. PubMed ID: 15931411 [TBL] [Abstract][Full Text] [Related]
28. Global preventive policies. Strategies at European and worldwide level. Kotseva K Rev Esp Cardiol; 2008 Sep; 61(9):960-70. PubMed ID: 18775238 [TBL] [Abstract][Full Text] [Related]
29. Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy. Tsang JL; Mendelsohn A; Tan MK; Hackam DG; Leiter LA; Fitchett D; Lin PJ; Grima E; Langer A; Goodman SG; Am J Cardiol; 2008 Nov; 102(9):1142-5. PubMed ID: 18940280 [TBL] [Abstract][Full Text] [Related]
30. Evidence-based guidelines for cardiovascular disease prevention in women. Mosca L; Appel LJ; Benjamin EJ; Berra K; Chandra-Strobos N; Fabunmi RP; Grady D; Haan CK; Hayes SN; Judelson DR; Keenan NL; McBride P; Oparil S; Ouyang P; Oz MC; Mendelsohn ME; Pasternak RC; Pinn VW; Robertson RM; Schenck-Gustafsson K; Sila CA; Smith SC; Sopko G; Taylor AL; Walsh BW; Wenger NK; Williams CL; Circulation; 2004 Feb; 109(5):672-93. PubMed ID: 14761900 [No Abstract] [Full Text] [Related]
31. Better management of cardiovascular diseases by pulse wave velocity: combining clinical practice with clinical research using evidence-based medicine. Khoshdel AR; Carney SL; Nair BR; Gillies A Clin Med Res; 2007 Mar; 5(1):45-52. PubMed ID: 17456834 [TBL] [Abstract][Full Text] [Related]
32. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. ; ; ; ; ; Heart; 2005 Dec; 91 Suppl 5(Suppl 5):v1-52. PubMed ID: 16365341 [No Abstract] [Full Text] [Related]
33. Identifying obese women most at risk from cardiovascular disease. Tonstad S Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S19-25; discussion S31-2. PubMed ID: 17968433 [TBL] [Abstract][Full Text] [Related]
34. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)]. Portolés J; López-Gómez JM; Aljama P Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011 [TBL] [Abstract][Full Text] [Related]
35. [Clinical guidelines for detection, prevention, diagnosis and treatment of systemic arterial hypertension in Mexico (2008)]. Rosas M; Pastelín G; Vargas-Alarcón G; Martínez-Reding J; Lomelí C; Mendoza-González C; Lorenzo JA; Méndez A; Franco M; Sánchez-Lozada LG; Verdejo J; Sánchez N; Ruiz R; Férez-Santander SM; Attie F; Arch Cardiol Mex; 2008; 78 Suppl 2():S2-5-57. PubMed ID: 18928127 [TBL] [Abstract][Full Text] [Related]
36. Is family history a useful tool for detecting children at risk for diabetes and cardiovascular diseases? A public health perspective. Valdez R; Greenlund KJ; Khoury MJ; Yoon PW Pediatrics; 2007 Sep; 120 Suppl 2():S78-86. PubMed ID: 17767009 [TBL] [Abstract][Full Text] [Related]
37. Ministry of health clinical practice guidelines: screening of cardiovascular disease and risk factors. Goh LG; Chua T; Kang V; Kwong KH; Lim WY; Low LP; Pereira J; Venketasubramanian N; Sethi SK; Sum CF; Tan CL; Tan HK; Tan SM; Wong TK; Singapore Med J; 2011 Mar; 52(3):220-5 quiz 226-7. PubMed ID: 21451932 [TBL] [Abstract][Full Text] [Related]
38. Prevention of cardiac disease: lifestyle modification or pharmacotherapy? Patel S; Adams MR Intern Med J; 2008 Mar; 38(3):199-203. PubMed ID: 18290814 [TBL] [Abstract][Full Text] [Related]
39. Common questions in managing hyperlipidemia. Rosen IM; Sams RW Prim Care; 2006 Dec; 33(4):903-21. PubMed ID: 17169673 [TBL] [Abstract][Full Text] [Related]
40. [Global risk and objectives in cardiovascular diseases]. Güleç S Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():1-10. PubMed ID: 19404044 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]